BOERS M

Last name: BOERS M

2021 (v1)

Publication

Metadata-only

Patients' and rheumatologists' perspectives on the efficacy and safety of low-dose glucocorticoids in rheumatoid arthritis-an international survey within the GLORIA study.

Santiago T Voshaar M de Wit M

No description

Uploaded on: February 14, 2024
2022 (v1)

Publication

Metadata-only

Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids.

Hartman L da Silva JAP Buttgereit F

No description

Uploaded on: January 31, 2024
2022 (v1)

Publication

Metadata-only

Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial.

Hartman L El Alili M Cutolo M

No description

Uploaded on: February 14, 2024
2006 (v1)

Publication

Metadata-only

Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

Da Silva JA Jacobs JW Kirwan JR

No description

Uploaded on: April 14, 2023
2023 (v1)

Publication

Metadata-only

Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial

Almayalım AAH Boers M Hartman L

Objective: The randomised placebo-controlled GLORIA (Glucocorticoid LOw-dose in RheumatoId Arthritis) trial evaluated the benefits and harms of prednisolone 5 mg/day added to standard care for 2 years in patients aged 65+ years with rheumatoid arthritis (RA). Here, we studied disease activity, flares and possible adrenal insufficiency after...

Uploaded on: February 13, 2024
2009 (v1)

Publication

Metadata-only

Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.

van der Goes MC Jacobs JW Boers M

No description

Uploaded on: April 14, 2023
2022 (v1)

Publication

Metadata-only

Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial.

Boers M Hartman L Opris-Belinski D

No description

Uploaded on: February 14, 2024
2013 (v1)

Publication

Metadata-only

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases.

Duru N van der Goes MC Jacobs JW

No description

Uploaded on: May 13, 2023
2010 (v1)

Publication

Metadata-only

Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice.

van der Goes MC Jacobs JW Boers M

No description

Uploaded on: March 31, 2023
2014 (v1)

Publication

Metadata-only

The EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.

Smolen JS Landewé R Breedveld FC

No description

Uploaded on: April 14, 2023

BOERS M

Recent uploads